{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:01:49Z","timestamp":1747170109554,"version":"3.40.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.retram.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T20:22:30Z","timestamp":1455913350000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Syndrome de TAFRO et gammapathie monoclonale\u00a0: association inhabituelle\u00a0!"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5644-678X","authenticated-orcid":false,"given":"M.","family":"Naifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Messedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Elleuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Snoussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gouiaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lahiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Boudawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ayedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2016.01.001_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pneumo.2012.12.005","article-title":"[Castleman's disease: unusual presentation of Castleman's disease and review of literature]","volume":"69","author":"Baranzelli","year":"2013","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.retram.2016.01.001_bib0115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45\u00a0cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2016.01.001_bib0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/asheducation.V2012.1.595.3798563","article-title":"Differential diagnosis of monoclonal gammopathy of undetermined significance","author":"Merlini","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.retram.2016.01.001_bib0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/asheducation-2005.1.360","article-title":"POEMS syndrome","author":"Dispenzieri","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.retram.2016.01.001_bib0130","first-page":"4","article-title":"[POEMS syndrome: a literature review and case reports]","volume":"114","author":"Piradov","year":"2014","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.retram.2016.01.001_bib0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/CMC.S15713","article-title":"Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach","volume":"8","author":"Houston","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.retram.2016.01.001_bib0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s005950050629","article-title":"Castleman's disease in the posterior mediastinum: report of a case","volume":"30","author":"Iyoda","year":"2000","journal-title":"Surg Today"},{"key":"10.1016\/j.retram.2016.01.001_bib0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/JTO.0b013e3181989edc","article-title":"Castleman's disease of the chest wall","volume":"4","author":"Ueda","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.retram.2016.01.001_bib0150","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2169\/internalmedicine.51.8120","article-title":"Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis","volume":"51","author":"Awano","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.retram.2016.01.001_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3960\/jslrt.53.101","article-title":"A case of multicentric Castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy","volume":"53","author":"Awano","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.retram.2016.01.001_bib0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2431-14-139","article-title":"The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease","volume":"14","author":"Kubokawa","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.retram.2016.01.001_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3960\/jslrt.53.57","volume":"53","author":"Kawabata","year":"2012","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.retram.2016.01.001_bib0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3960\/jslrt.53.87","article-title":"Atypical hyaline vascular-type Castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy","volume":"53","author":"Iwaki","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.retram.2016.01.001_bib0175","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8\u00a0is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.retram.2016.01.001_bib0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0961203310381510","article-title":"Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases","volume":"20","author":"Kojima","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.retram.2016.01.001_bib0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.167.2.332","article-title":"The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells","volume":"167","author":"Muraguchi","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.retram.2016.01.001_bib0190","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.141.9.3072","article-title":"Human recombinant IL-6\/B cell stimulatory factor 2\u00a0augments murine antigen-specific antibody responses in vitro and in vivo","volume":"141","author":"Takatsuki","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.retram.2016.01.001_bib0195","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2169\/internalmedicine.52.9482","article-title":"Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6\u00a0receptor antibody","volume":"52","author":"Kawabata","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.retram.2016.01.001_bib0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/107327481402100403","article-title":"Diagnosis and management of Castleman disease","volume":"21","author":"Soumerai","year":"2014","journal-title":"Cancer Control"},{"key":"10.1016\/j.retram.2016.01.001_bib0205","first-page":"350","article-title":"[Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease]","volume":"55","author":"Ozawa","year":"2014","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.retram.2016.01.001_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.53.95","article-title":"Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A: a case report","volume":"53","author":"Inoue","year":"2013","journal-title":"J Clin Exp Hematop"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318616000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318616000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T23:18:18Z","timestamp":1692227898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318616000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2452318616000027"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2016.01.001","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome de TAFRO et gammapathie monoclonale\u00a0: association inhabituelle\u00a0!","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}